Rosa Nadal

5.4k total citations · 1 hit paper
48 papers, 1.9k citations indexed

About

Rosa Nadal is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Rosa Nadal has authored 48 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pulmonary and Respiratory Medicine, 18 papers in Radiology, Nuclear Medicine and Imaging and 17 papers in Oncology. Recurrent topics in Rosa Nadal's work include Prostate Cancer Treatment and Research (23 papers), Radiopharmaceutical Chemistry and Applications (18 papers) and Bladder and Urothelial Cancer Treatments (15 papers). Rosa Nadal is often cited by papers focused on Prostate Cancer Treatment and Research (23 papers), Radiopharmaceutical Chemistry and Applications (18 papers) and Bladder and Urothelial Cancer Treatments (15 papers). Rosa Nadal collaborates with scholars based in United States, Spain and Canada. Rosa Nadal's co-authors include Joaquim Bellmunt, Emmanuel S. Antonarakis, Mario A. Eisenberger, Brandon Luber, Michael A. Carducci, Michael T. Schweizer, Channing J. Paller, Samuel R. Denmeade, Hao Wang and Mari Nakazawa and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Rosa Nadal

46 papers receiving 1.9k citations

Hit Papers

Androgen Receptor Splice Variant 7 and Efficacy of Taxane... 2015 2026 2018 2022 2015 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer
    2015 466 citations Emmanuel S. Antonarakis, Rosa Nadal et al. profile →

Peers

Rosa Nadal
K.N. Chi Canada
Benjamin L. Maughan United States
Martin Boegemann Germany
Pasquale Rescigno Italy
Diletta Bianchini United Kingdom
Tony Elliott United Kingdom
Damien Pouessel France
Alejo Rodríguez‐Vida Spain
Mario Eisenberger United States
Sebastian Rogenhofer Germany
K.N. Chi Canada
Rosa Nadal
Citations per year, relative to Rosa Nadal Rosa Nadal (= 1×) peers K.N. Chi

Countries citing papers authored by Rosa Nadal

Since Specialization
Citations

This map shows the geographic impact of Rosa Nadal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosa Nadal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosa Nadal more than expected).

Fields of papers citing papers by Rosa Nadal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosa Nadal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosa Nadal. The network helps show where Rosa Nadal may publish in the future.

Co-authorship network of co-authors of Rosa Nadal

This figure shows the co-authorship network connecting the top 25 collaborators of Rosa Nadal. A scholar is included among the top collaborators of Rosa Nadal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosa Nadal. Rosa Nadal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Vlachou, Evangelia, Burles A. Johnson, Ezra Baraban, Rosa Nadal, & Jean Hoffman‐Censits. (2024). Current Advances in the Management of Nonurothelial Subtypes of Bladder Cancer. American Society of Clinical Oncology Educational Book. 44(3). e438640–e438640. 4 indexed citations
3.
Nadal, Rosa, Begoña P. Valderrama, & Joaquim Bellmunt. (2023). Progress in systemic therapy for advanced-stage urothelial carcinoma. Nature Reviews Clinical Oncology. 21(1). 8–27. 37 indexed citations
4.
Cherkasova, Elena, Rosa Nadal, Long Chen, et al.. (2023). T cell receptor-engineered T cells targeting a human endogenous retrovirus in kidney cancer.. Journal of Clinical Oncology. 41(16_suppl). 4542–4542. 2 indexed citations
5.
Nadal, Rosa, Joseph Clara, Begoña P. Valderrama, & Joaquim Bellmunt. (2021). Current Therapy for Metastatic Urothelial Carcinoma. Hematology/Oncology Clinics of North America. 35(3). 469–493. 5 indexed citations
6.
Nadal, Rosa, Andrea B. Apolo, Daniel M. Girardi, Noah M. Hahn, & Joaquim Bellmunt. (2020). Systemic therapy issues: Immunotherapy in nonmetastatic urothelial cancer. Urologic Oncology Seminars and Original Investigations. 41(1). 27–34. 5 indexed citations
7.
Bowden, Michaela, Rosa Nadal, Chensheng W. Zhou, et al.. (2020). Transcriptomic analysis of micropapillary high grade T1 urothelial bladder cancer. Scientific Reports. 10(1). 20135–20135. 9 indexed citations
8.
Nadal, Rosa & Joaquim Bellmunt. (2019). Management of metastatic bladder cancer. Cancer Treatment Reviews. 76. 10–21. 188 indexed citations
9.
10.
Bellmunt, Joaquim & Rosa Nadal. (2017). Changes in expectations for metastatic urothelial carcinoma. Nature Reviews Clinical Oncology. 15(2). 73–74. 2 indexed citations
11.
12.
Rowe, Steven P., Katarzyna J. Macura, Esther Mena, et al.. (2016). PSMA-Based [18F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer. Molecular Imaging and Biology. 18(3). 411–419. 199 indexed citations
13.
Nadal, Rosa, Howard L. Parnes, Lisa M. Cordes, et al.. (2016). A phase II study of cabozantinib in patients (pts) with relapsed/refractory metastatic urothelial carcinoma (mUC). Annals of Oncology. 27. vi272–vi272. 2 indexed citations
14.
Rowe, Steven P., Katarzyna J. Macura, Anthony Ciarallo, et al.. (2015). Comparison of Prostate-Specific Membrane Antigen–Based 18F-DCFBC PET/CT to Conventional Imaging Modalities for Detection of Hormone-Naïve and Castration-Resistant Metastatic Prostate Cancer. Journal of Nuclear Medicine. 57(1). 46–53. 94 indexed citations
15.
Nadal, Rosa, Hua‐Ling Tsai, Victoria J. Sinibaldi, et al.. (2015). Prognostic factors for clinical outcomes in patients with metastatic castration resistant prostate cancer treated with sequential novel androgen receptor‐directed therapies. The Prostate. 76(5). 512–520. 16 indexed citations
16.
Cheng, Heather H., Roman Gulati, Arun Azad, et al.. (2015). Activity of enzalutamide in men with metastatic castration-resistant prostate cancer is affected by prior treatment with abiraterone and/or docetaxel. Prostate Cancer and Prostatic Diseases. 18(2). 122–127. 71 indexed citations
17.
Nadal, Rosa & Joaquim Bellmunt. (2014). New Treatments for Bladder Cancer: When Will We Make Progress?. Current Treatment Options in Oncology. 15(1). 99–114. 15 indexed citations
18.
Nadal, Rosa, Michael T. Schweizer, Oleksandr N. Kryvenko, Jonathan I. Epstein, & Mario A. Eisenberger. (2014). Small cell carcinoma of the prostate. Nature Reviews Urology. 11(4). 213–219. 184 indexed citations
19.
Nadal, Rosa, José A. Lorente, R. Rosell, & María José Serrano. (2013). Relevance of molecular characterization of circulating tumor cells in breast cancer in the era of targeted therapies. Expert Review of Molecular Diagnostics. 13(3). 295–307. 24 indexed citations
20.
Nadal, Rosa, Zsuzsanna H. McMahan, & Emmanuel S. Antonarakis. (2013). Paraneoplastic Palmar Fasciitis and Polyarthritis Syndrome in a Patient With Advanced Prostate Cancer. Clinical Genitourinary Cancer. 11(4). e15–e23. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K.N. Chi Breakdown of academic impact, for papers by Benjamin L. Maughan Breakdown of academic impact, for papers by Martin Boegemann Breakdown of academic impact, for papers by Pasquale Rescigno Breakdown of academic impact, for papers by Diletta Bianchini Breakdown of academic impact, for papers by Tony Elliott Breakdown of academic impact, for papers by Damien Pouessel Breakdown of academic impact, for papers by Alejo Rodríguez‐Vida Breakdown of academic impact, for papers by Mario Eisenberger Breakdown of academic impact, for papers by Sebastian Rogenhofer
Rankless by CCL
2026